BridgeMD
Tests treatment safety and results for Myocardial Infarction
Official title Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar: The AGTP II Trial
ClinicalTrials.gov ID: NCT02798276
What this study is testing
- What it's testing
- The purpose of this trial is to evaluate the efficacy of a pericardial adipose graft transposition (Adipose Graft Trasposition Procedure, AGTP) for the improvement of cardiac function in patients with a chronic myocardial infarction. Preclinical studies in the porcine model of myocardial infarction have shown that the AGTP reduces infarct area and improves cardiac function.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \> 18 years of age, capable of giving informed consent.
- Q wave in the ECG
- Myocardial infarct \>=50% transmularity by NMR non revascularizable (for transmurality or bad vessel).
- Candidate to bypass for other myocardial areas
You likely can't join if
- Severe non cardiac co-morbidity with a reduction of life expectancy of less than 1 year
- Severe valvular disease candidate for surgical restoration
- Candidate to ventricular remodeling
- Contraindication for NMR
- Severe renal or hepatic failure
- Abnoraml laboratory tests (no explanation at inclusion)
See the full eligibility criteria
- \> 18 years of age, capable of giving informed consent.
- Q wave in the ECG
- Myocardial infarct \>=50% transmularity by NMR non revascularizable (for transmurality or bad vessel).
- Candidate to bypass for other myocardial areas
- Severe non cardiac co-morbidity with a reduction of life expectancy of less than 1 year
- Severe valvular disease candidate for surgical restoration
- Candidate to ventricular remodeling
- Contraindication for NMR
- Severe renal or hepatic failure
- Abnoraml laboratory tests (no explanation at inclusion)
- Previous cardiac intervention
- Pregnant or breast feeding women
The study team makes the final eligibility decision.
Where it's taking place
- Badalona, Barcelona, Spain
- Majadahonda, Madrid, Spain
- Oviedo, Principality of Asturias, Spain
- Madrid, Spain
- Málaga, Spain
- Murcia, Spain
- Palma de Mallorca, Spain
- Valencia, Spain
- Valladolid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Badalona, Barcelona, Spain; Majadahonda, Madrid, Spain; Oviedo, Principality of Asturias, Spain; Madrid, Spain; Málaga, Spain; Murcia, Spain and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.